StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3056% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

Medifast cash

Cash and short-term investments held at the end of each period.

Medifast's cash was $172.24M at Sep 30, 2026. For fiscal 2025 it was $166.35M, up 0.4% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $174.48M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$166.35M+0.4%
FY2024Dec 31, 2024$165.62M+11.0%
FY2023Dec 31, 2023$149.16M+70.1%
FY2022Dec 31, 2022$87.69M-19.9%
FY2021Dec 31, 2021$109.46M-37.3%
FY2020Dec 31, 2020$174.48M+88.3%
FY2019Dec 31, 2019$92.68M-8.3%
FY2018Dec 31, 2018$101.03M+2.2%
FY2017Dec 31, 2017$98.83M+28.6%
FY2016Dec 31, 2016$76.85M+14.5%
FY2015Dec 31, 2015$67.11M+27.5%
FY2014Dec 31, 2014$52.64M-22.4%
FY2013Dec 31, 2013$67.80M+13.0%
FY2012Dec 31, 2012$59.99M+77.5%
FY2011Dec 31, 2011$33.80M-1.8%
FY2010Dec 31, 2010$34.44M+224.7%
FY2009Dec 31, 2009$10.60M+989.8%
FY2008Dec 31, 2008$973.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$172.24M-0.3%
Q2 FY2026Jun 30, 2026$169.23M+4.5%
Q1 FY2026Mar 31, 2026$168.44M+0.8%
Q4 FY2025Dec 31, 2025$166.35M+0.4%
Q3 FY2025Sep 30, 2025$172.81M+0.1%
Q2 FY2025Jun 30, 2025$161.91M-1.7%
Q1 FY2025Mar 31, 2025$167.14M+9.0%
Q4 FY2024Dec 31, 2024$165.62M+11.0%
Q3 FY2024Sep 30, 2024$172.65M+9.6%
Q2 FY2024Jun 30, 2024$164.72M+11.7%
Q1 FY2024Mar 31, 2024$153.34M+23.9%
Q4 FY2023Dec 31, 2023$149.16M+70.1%
Q3 FY2023Sep 30, 2023$157.47M+125.9%
Q2 FY2023Jun 30, 2023$147.41M+141.4%
Q1 FY2023Mar 31, 2023$123.75M+1.4%
Q4 FY2022Dec 31, 2022$87.69M-19.9%
Q3 FY2022Sep 30, 2022$69.71M-56.4%
Q2 FY2022Jun 30, 2022$61.07M-69.1%
Q1 FY2022Mar 31, 2022$122.06M-42.7%
Q4 FY2021Dec 31, 2021$109.46M-37.3%
Q3 FY2021Sep 30, 2021$159.90M-5.9%
Q2 FY2021Jun 30, 2021$197.43M+35.8%
Q1 FY2021Mar 31, 2021$212.91M+102.3%
Q4 FY2020Dec 31, 2020$174.48M+88.3%
Q3 FY2020Sep 30, 2020$169.92M+75.3%
Q2 FY2020Jun 30, 2020$145.39M+28.1%
Q1 FY2020Mar 31, 2020$105.26M-12.6%
Q4 FY2019Dec 31, 2019$92.68M-8.3%
Q3 FY2019Sep 30, 2019$96.91M-6.1%
Q2 FY2019Jun 30, 2019$113.52M+9.9%
Q1 FY2019Mar 31, 2019$120.43M+10.2%
Q4 FY2018Dec 31, 2018$101.03M+2.2%
Q3 FY2018Sep 30, 2018$103.22M+7.8%
Q2 FY2018Jun 30, 2018$103.32M+16.7%
Q1 FY2018Mar 31, 2018$109.24M+38.4%
Q4 FY2017Dec 31, 2017$98.83M+28.6%
Q3 FY2017Sep 30, 2017$95.73M–
Q2 FY2017Jun 30, 2017$88.55M–
Q1 FY2017Mar 31, 2017$78.96M–
Q4 FY2016Dec 31, 2016$76.85M–

More Medifast figures

See a number that looks wrong?